| ■ 영문 제목 : Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02363 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 105 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료장치 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (PCR, In Situ 하이브리드, 칩 마이크로어레이, 등온 핵산 증폭 기술 (Inaat), 질량 분석, 시퀀싱, 전사 매개 증폭 기술 (Inaat),)와 용도별 시장규모 (병원, 연구, 클리닉, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장 점유율 - 지역별 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장규모 - 주요지역의 종류별 시장규모 (PCR, In Situ 하이브리드, 칩 마이크로어레이, 등온 핵산 증폭 기술 (Inaat), 질량 분석, 시퀀싱, 전사 매개 증폭 기술 (Inaat),) - 주요지역의 용도별 시장규모 (병원, 연구, 클리닉, 기타) - 미주의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche, Bayer Healthcare, Dako, Abbott Laboratories, Danaher, Siemens, Sysmex, Grifols, Biomérieux - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment will have significant change from previous year. By the most conservative estimates of global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Pcr
In Situ Hybridization
Chips And Microarrays
Isothermal Nucleic Acid Amplification Technology (Inaat)
Mass Spectrometry
Sequencing
Transcription Mediated Amplification
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Research
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Cepheid
Beckton Dickinson
Gen Probe (Hologic)
Qiagen
Roche
Bayer Healthcare
Dako
Abbott Laboratories
Danaher
Siemens
Sysmex
Grifols
Biomérieux
1 Scope of the Report 2 Executive Summary 3 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment by Company 4 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Pcr Table 3. Major Players of In Situ Hybridization Table 4. Major Players of Chips And Microarrays Table 5. Major Players of Isothermal Nucleic Acid Amplification Technology (Inaat) Table 6. Major Players of Mass Spectrometry Table 7. Major Players of Sequencing Table 8. Major Players of Transcription Mediated Amplification Table 9. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Type (2016-2021) & (K Units) Table 10. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type (2016-2021) Table 11. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Type (2016-2021) & ($ million) Table 12. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Type (2016-2021) Table 13. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sale Price by Type (2016-2021) Table 14. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Application (2016-2021) & (K Units) Table 15. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2016-2021) Table 16. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Value by Application (2016-2021) Table 17. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Application (2016-2021) Table 18. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sale Price by Application (2016-2021) Table 19. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Company (2019-2021) & (K Units) Table 20. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Company (2019-2021) Table 21. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Company (2019-2021) ($ Millions) Table 22. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Company (2019-2021) Table 23. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sale Price by Company (2019-2021) Table 24. Key Manufacturers Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Producing Area Distribution and Sales Area Table 25. Players Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Products Offered Table 26. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 27. New Products and Potential Entrants Table 28. Mergers & Acquisitions, Expansion Table 29. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Region (2016-2021) (K Units) Table 30. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Region (2016-2021) Table 31. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Region (2016-2021) & ($ Millions) Table 32. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Region (2016-2021) Table 33. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Country (2016-2021) & (K Units) Table 34. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Country (2016-2021) Table 35. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Country (2016-2021) & ($ Millions) Table 36. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Country (2016-2021) Table 37. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Type (2016-2021) & (K Units) Table 38. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type (2016-2021) Table 39. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Application (2016-2021) & (K Units) Table 40. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2016-2021) Table 41. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Region (2016-2021) & (K Units) Table 42. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Region (2016-2021) Table 43. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Region (2016-2021) & ($ Millions) Table 44. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Region (2016-2021) Table 45. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Type (2016-2021) & (K Units) Table 46. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type (2016-2021) Table 47. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Application (2016-2021) & (K Units) Table 48. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2016-2021) Table 49. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Country (2016-2021) & (K Units) Table 50. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Country (2016-2021) Table 51. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Country (2016-2021) & ($ Millions) Table 52. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Country (2016-2021) Table 53. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Type (2016-2021) & (K Units) Table 54. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type (2016-2021) Table 55. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Application (2016-2021) & (K Units) Table 56. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2016-2021) Table 57. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Country (2016-2021) & (K Units) Table 58. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Country (2016-2021) Table 59. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue by Country (2016-2021) & ($ Millions) Table 60. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Country (2016-2021) Table 61. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Type (2016-2021) & (K Units) Table 62. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type (2016-2021) Table 63. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Application (2016-2021) & (K Units) Table 64. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2016-2021) Table 65. Key and Potential Regions of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Table 66. Key Application and Potential Industries of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Table 67. Key Challenges of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Table 68. Key Trends of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Table 69. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Distributors List Table 70. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Customer List Table 71. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Region (2021-2026) & (K Units) Table 72. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Consumption Market Forecast by Region Table 73. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share Forecast by Region (2021-2026) Table 75. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Country (2021-2026) & (K Units) Table 76. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Region (2021-2026) & (K Units) Table 78. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Region (2021-2026) & ($ millions) Table 79. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Country (2021-2026) & (K Units) Table 80. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Country (2021-2026) & ($ millions) Table 81. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Country (2021-2026) & (K Units) Table 82. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Country (2021-2026) & ($ millions) Table 83. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Type (2021-2026) & (K Units) Table 84. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share Forecast by Type (2021-2026) Table 85. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Type (2021-2026) & ($ Millions) Table 86. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share Forecast by Type (2021-2026) Table 87. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Application (2021-2026) & (K Units) Table 88. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share Forecast by Application (2021-2026) Table 89. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Forecast by Application (2021-2026) & ($ Millions) Table 90. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share Forecast by Application (2021-2026) Table 91. Cepheid Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 92. Cepheid Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 93. Cepheid Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 94. Cepheid Main Business Table 95. Cepheid Latest Developments Table 96. Beckton Dickinson Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 97. Beckton Dickinson Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 98. Beckton Dickinson Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 99. Beckton Dickinson Main Business Table 100. Beckton Dickinson Latest Developments Table 101. Gen Probe (Hologic) Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 102. Gen Probe (Hologic) Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 103. Gen Probe (Hologic) Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 104. Gen Probe (Hologic) Main Business Table 105. Gen Probe (Hologic) Latest Developments Table 106. Qiagen Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 107. Qiagen Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 108. Qiagen Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 109. Qiagen Main Business Table 110. Qiagen Latest Developments Table 111. Roche Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 112. Roche Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 113. Roche Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 114. Roche Main Business Table 115. Roche Latest Developments Table 116. Bayer Healthcare Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 117. Bayer Healthcare Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 118. Bayer Healthcare Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 119. Bayer Healthcare Main Business Table 120. Bayer Healthcare Latest Developments Table 121. Dako Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 122. Dako Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 123. Dako Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 124. Dako Main Business Table 125. Dako Latest Developments Table 126. Abbott Laboratories Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 127. Abbott Laboratories Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 128. Abbott Laboratories Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 129. Abbott Laboratories Main Business Table 130. Abbott Laboratories Latest Developments Table 131. Danaher Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 132. Danaher Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 133. Danaher Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 134. Danaher Main Business Table 135. Danaher Latest Developments Table 136. Siemens Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 137. Siemens Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 138. Siemens Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 139. Siemens Main Business Table 140. Siemens Latest Developments Table 141. Sysmex Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 142. Sysmex Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 143. Sysmex Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 144. Sysmex Main Business Table 145. Sysmex Latest Developments Table 146. Grifols Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 147. Grifols Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 148. Grifols Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 149. Grifols Main Business Table 150. Grifols Latest Developments Table 151. Biomérieux Basic Information, Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors Table 152. Biomérieux Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered Table 153. Biomérieux Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 154. Biomérieux Main Business Table 155. Biomérieux Latest Developments List of Figures Figure 1. Picture of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Figure 2. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Pcr Figure 10. Product Picture of In Situ Hybridization Figure 11. Product Picture of Chips And Microarrays Figure 12. Product Picture of Isothermal Nucleic Acid Amplification Technology (Inaat) Figure 13. Product Picture of Mass Spectrometry Figure 14. Product Picture of Sequencing Figure 15. Product Picture of Transcription Mediated Amplification Figure 16. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type in 2020 Figure 17. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Type (2016-2021) Figure 18. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Consumed in Hospital Figure 19. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market: Hospital (2016-2021) & (K Units) Figure 20. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Consumed in Research Figure 21. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market: Research (2016-2021) & (K Units) Figure 22. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Consumed in Clinic Figure 23. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market: Clinic (2016-2021) & (K Units) Figure 24. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Consumed in Others Figure 25. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market: Others (2016-2021) & (K Units) Figure 26. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2016-2021) Figure 27. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Application in 2020 Figure 28. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market by Company in 2020 ($ Million) Figure 29. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Company in 2020 Figure 30. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Regions (2016-2021) Figure 31. Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Region in 2020 Figure 32. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales 2016-2021 (K Units) Figure 33. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue 2016-2021 ($ Millions) Figure 34. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales 2016-2021 (K Units) Figure 35. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue 2016-2021 ($ Millions) Figure 36. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales 2016-2021 (K Units) Figure 37. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue 2016-2021 ($ Millions) Figure 38. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales 2016-2021 (K Units) Figure 39. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue 2016-2021 ($ Millions) Figure 40. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Country in 2020 Figure 41. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Country in 2020 Figure 42. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type in 2020 Figure 43. Americas Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application in 2020 Figure 44. United States Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 45. Canada Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 46. Mexico Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 47. Brazil Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 48. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Region in 2020 Figure 49. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Regions in 2020 Figure 50. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type in 2020 Figure 51. APAC Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application in 2020 Figure 52. China Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 53. Japan Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 54. Korea Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 55. Southeast Asia Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 56. India Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 57. Australia Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 58. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Country in 2020 Figure 59. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Country in 2020 Figure 60. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type in 2020 Figure 61. Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application in 2020 Figure 62. Germany Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 63. France Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 64. UK Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 65. Italy Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 66. Russia Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 67. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Country in 2020 Figure 68. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Country in 2020 Figure 69. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Type in 2020 Figure 70. Middle East & Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application in 2020 Figure 71. Egypt Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 72. South Africa Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 73. Israel Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 74. Turkey Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 75. GCC Country Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions) Figure 76. Channels of Distribution Figure 77. Distributors Profiles |
| ※본 조사보고서 [세계의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장예측 2021년-2026년] (코드 : LPI-2201K02363) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 분자 클라미디아 트라코마티스 (CT)/나이세리아 임질 (NG) 진단 장비 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |